Rankings
▼
Calendar
AMRN Q1 2018 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$335M
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$44M
+26.8% YoY
Gross Profit
$33M
75.8% margin
Operating Income
-$22M
-49.9% margin
Net Income
-$24M
-54.9% margin
EPS (Diluted)
$-1.69
QoQ Revenue Growth
-18.5%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$216M
Total Liabilities
$232M
Stockholders' Equity
-$17M
Cash & Equivalents
$129M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$44M
$35M
+26.8%
Gross Profit
$33M
$26M
+25.8%
Operating Income
-$22M
-$19M
-18.0%
Net Income
-$24M
-$21M
-15.1%
← FY 2018
All Quarters
Q2 2018 →